-
Recent Posts
Recent Comments
Categories
- America Invents Act
- Analgous Art
- Anticipation (35 USC 102)
- Antitrust
- Appeal
- Arbitration
- Article III disputes
- Assignment / Ownership
- Attorney's Fees
- Best mode
- Biosimilars
- Business methods
- Certificate of Correction
- Claim
- Claim Construction
- Claim Differentiation
- Claim Preclusion
- Claim Vitiation
- Collateral estoppel
- Conception and Reduction to Practice
- Contributory Infringement
- Copyright
- Covered Business Method Reviews
- Damages
- Derivation of Invention
- Design Patents
- Diligence
- Disclaimers
- Discovery
- Doctrine of equivalents
- Double Patenting
- Enablement
- Equitable estoppel
- Experimental Use
- Expert Testimony
- False Marking
- Functional limitations
- Generics / ANDA
- Importation
- Indefiniteness
- Inducement to Infringe
- Inequitable Conduct
- Infringement
- Inherency
- Injunction
- Inter Parties Review (IPR)
- Interference
- International Trade Commission
- Inventorship
- IPR
- Issue Preclusion
- Jurisdiction
- Laches
- Licensing
- Lost Profits
- Malpractice
- Means-plus-function
- Method claims
- Negative Limitations
- Obviousness
- Obviousness-Teaching Away
- On-Sale Bar
- Patent Exhaustion
- Patent Marking
- Patent Prosecution
- Patent Term Adjustment (PTA)
- Patent Term Extension
- Patentability
- Post-grant review
- Preamble
- Priority
- Privilege
- Procedural Issues
- Product-by-Process
- Prosecution History Estoppel
- Public Use
- Reexamination
- Reissue
- Royalties
- Software
- Summary Judgment
- Trade Dress
- Trade Secret
- Trademarks
- U.S. Supreme Court
- Uncategorized
- Unenforceability
- Unjust enrichment
- Venue
- Willfullness
- Written description
Archives
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- July 2011
- February 2011
- January 2011
Meta
- America Invents Act Anticipation (35 USC 102) Appeal Article III disputes Assignment / Ownership Attorney's Fees Claim Construction Claim Differentiation Collateral estoppel Damages Doctrine of equivalents Generics / ANDA Indefiniteness Inducement to Infringe Inequitable Conduct Infringement Injunction Inter Parties Review (IPR) IPR Means-plus-function Obviousness Obviousness-Teaching Away Patentability Prosecution History Estoppel Reexamination Software Trademarks Uncategorized Willfullness Written description
Copyright Notice
© Patrick J. Halloran, Ph.D., J.D. and lifescienceip.wordpress.com, [2011-2017]. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Patrick J. Halloran, Ph.D., J.D. and lifescienceip.wordpress.com with appropriate and specific direction to the original content.
Monthly Archives: September 2017
NFC Technology, LLC v. Joseph Matal (USPTO)
Docket No. 2016-1808 (IPR2014-01198) LOURIE, REYNA, STOLL September 20, 2017 Brief summary: PTAB IPR FWD of invalidity for obviousness reversed and remanded as sufficient evidence corroborated inventor’s testimony regarding conception, and it must decide whether a prototype embodied the claimed … Continue reading
In Re: Cray Inc.
Docket No. 2017-129 LOURIE, REYNA, STOLL September 21, 2017 Brief summary: Cray was found not to the meet the FC’s venue requirements (e.g., employee’s home office was not a “regular and established place of business”) and the writ of mandamus … Continue reading
Posted in Venue
Leave a comment
Mylan Laboratories Limited v. Aventis Pharma S.A.
Case No. IPR2016-00712 (U.S. Pat. No. 8,927,592 B2) Final Written Decision September 21, 2017 Brief summary: FWD concludes Mylan showed the ‘592 claims are invalid for obviousness. Summary: The ‘592 patent is one of three patents listed on the FDA … Continue reading
Posted in Inter Parties Review (IPR), IPR, Obviousness
Leave a comment
Intellectual Ventures I LLC, et al. v. Motorola Mobility LLC et al.
Docket No. 2016-1795 NEWMAN (C/D), DYK, TARANTO September 13, 2017 Brief summary: DC denial of JMOL to Motorola affirmed with respect to invalidity but reversed as to direct infringement under 35 USC § 271(a) (e.g., “the end user must be … Continue reading
Waymo LLC v. Uber Technologies, Inc./Ottomoto/Otto Trucking (Defendants), Anthony Levandowski (Intervenor)
Docket No. 2017-2130 NEWMAN, WALLACH, STOLL September 13, 2017 Brief summary: DC denial of Uber’s motion to compel arbitration of litigation with Waymo affirmed. Summary: Uber appealed DC denial of its motion to compel arbitration of litigation with Waymo. Uber … Continue reading
Posted in Arbitration
Leave a comment
Waymo LLC v. Uber Technologies, Inc./Ottomoto (Defendants), Anthony Levandowski (intervenor), and Lyft, Inc. et al. (Movants)
Docket No. 2017-2235, -2253 NEWMAN, WALLACH, STOLL September 13, 2017 Brief summary: Mr. Levandowski’s petition for writ of mandamus was denied because, e.g., he could not show protection under attorney-client privilege or the work-product doctrine. Summary: Waymo sued Uber et … Continue reading
Posted in Appeal, Discovery, Privilege
Leave a comment
Allied Mineral Products, Inc. v. OSMI, Inc. et al. (“Stellar”)
Docket No. 2016-2641 MOORE, REYNA, STOLL September 13, 2017 Brief summary: DC dismissal for lack of subject matter jurisdiction since Stellar only took action against Allied’s distributors in MX but no action against Allied (in MX or the US). Summary: … Continue reading